Integrate patient and provider voices into your research
Capture patient experiences and physician perspectives
Claims and electronic health records (EHR) frequently tell only part of the story. Patients don’t always take their medications as prescribed, or they may have unexpected side effects. Their conditions may be affecting their whole family, or their work productivity may be affected by their treatments.
And while physicians commonly document their interactions with patients, they may not disclose their own attitudes about a condition, its treatment options or its economic burden. It’s important for life sciences companies to capture patient experiences and physician perspectives that come from a range of sources, including regulatory guidelines, social media and patient interactions. This is where our Voice-to-Claim research methodology comes into play.
The Optum Health Economics and Outcomes Research (HEOR) team works with our clients to define a study-specific cohort and works with a third party to reach out to patients and their physicians to participate in Voice-to-Claim research.
We link the new intelligence back to cost and utilization information that’s derived from de-identified clinical or claims data — all while maintaining patient privacy. Our HEOR researchers never see identifiable data, protecting the interests of both the patient and the sponsor. These new data can help clients close critical gaps in knowledge and uncover greater levels of insight.
Explore the full patient journey
See how Voice-to-Claim research was used to help 2 pharmaceutical companies understand a difficult-to-study condition.
Valery Walker, MSc
Since joining Optum in 1992, Valery’s research has spanned numerous therapeutic areas and types of projects.
Yiran Zhang, PhD
Yiran is a senior researcher in the PDC group and has worked in the therapeutic areas of opioid use disorder and schizophrenia.
Key benefits
Unlock the value of design research by exploring patient and physician perspectives on treatment decisions.
Demonstrate value of treatments to payers
Investigate patient and physician attitudes about treatment and insights into how decisions are made.
Bring patient-centric evidence to regulators
Expand your label by illustrating a treatment’s impact on quality of life and effects on productivity.
Illustrate patient value to physicians
Leverage data that can help you guide prescribing patterns over time by examining disease burden and healthcare utilization.
Harris SB, Mohammedi K, Bertolini M, White J, Walker V, Zhou FL, Anderson JE, Seufert J. Patient Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes in the United States: A Cross-Sectional Survey. Diabetes Obes Metab. 2023 May;25(5):1408-12. doi: 10.1111/dom.14973. Epub 2023 Jan 31.
Harris SB, Seufert J, Bertolini M, Walker V, White JC, Zhou FL, Mohammedi K, Anderson JE. Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey. Diabetes. 1 June 2022; 71 (Supplement_1):512–P. https://doi.org/10.2337/db22-512-P
Harris SB, Mohammedi K, Bertolini M, Walker V, Carlyle MH, Zhou FL, Seufert J, Anderson JE. Patient and Physician Experience of Hypoglycemia During Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S. Diabetes. 1 June 2022; 71 (Supplement_1):379–P. https://doi.org/10.2337/db22-379-P
Harris S, Mohammedi K, Bertolini M, White J, Carlyle M, Zhou FL, Anderson J, Seufert J. Patient Perspectives and Experiences of Basal Insulin (BI) Titration in Type 2 Diabetes (T2D): A US Cross-Sectional Survey. Metabolism. 2022;128 (Supplement):155051. https://doi.org/10.1016/j.metabol.2021.155051
Moretz C, Hahn B, White J, Goolsby Hunter A, Essoi B, Elliott C, Ray R. Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy. Int J Chron Obstruct Pulmon Dis. 2020 Oct 29;15:2715-25.
Taylor DC, Abel J, Doshi JA, Martin C, Goolsby Hunter A, Essoi B, Korrer S, Reasner DS, Carson RT, Chey WD. The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated with Linaclotide or Other Medications: Real-World Evidence from the CONTOR Study. J Clin Gastroenterol. 2019 Nov/Dec;53(10):737-43.
Wei W, Ghorayeb E, Andria ML, Walker V, Schnitzer J, Kennedy M, Chen Z, Belland A, White J, Silverberg JL. A Real-world Study Evaluating AdeQUacy of Existing Systemic Treatments for Patients with Moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline Treatment Patterns and Unmet Needs Assessment. Ann Allergy Asthma Immunol. 2019;123(4):381-88.
Hahn B, Stanford RH, Goolsby Hunter A, Essoi B, White J, Ray R. Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-linked Survey Study. Pulm Ther. 2019;5(2):179-90.
Ray H, Hahn B, Stanford R, White J, Essoi B, Hunter A. Classification of Patients with COPD on LAMA Monotherapy using the GOLD Criteria: Analysis of a Claims-linked Patient Survey Study. Pulm Ther. 2019;5:191.
Strange C, Walker V, Depietro M, Tong J, Kurlander J, Carlyle M, Millette LA, Wittbrodt E. Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:1377-88.
Hahn B, Stanford RH, Goolsby Hunter A, Essoi B, White J, Ray R. Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study. Pulm Ther. 2019 Jun;5(1):69-80.
Stanford RH, Bell C, Nag A, Johnson PT, Johnson MP, Watkins A. Cross-sectional survey study to examine underuse of twice daily inhaled maintenance therapy among patients with asthma. J Asthma. 2019 Nov;56(11):1172-181. doi: 10.1080/02770903.2018.1531994. Epub 2018 Nov 5.
Johnson K, Brenneman SK, Newransky C, Sheffler-Collins S, Becker LK, Belland A, Acosta CJ. A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality-of-life questionnaire. BMC Health Serv Res. 2018 Aug 25;18(1):662.
Lofland JH, Johnson PT, Ingham MP, Rosemas SC, White JC, Ellis L. Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs. Patient Prefer Adherence. 2017 May 18;11:947-58.
Zhang M, Carter C, Olson WH, Johnson MP, Brenneman SK, Lee S, Farahi K. Patient preference for dosing frequency based on prior biologic experience. J Drugs Dermatol. 2017 Mar;16(3):220-26.
Wei W, Buysman E, Grabner M, Xie L, Brekke L, Ke X, Chu JW, Levin PA. A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies. Diabetes Obes Metab. 2017 Mar;19(3):375-86.
White JC, Hartley S, Ozminkowski RJ. Association between corporate wellness program participation and changes in health risks. J Occup Environ Med. 2015 Oct;57(10):1119-26.
Walker V, Patel H, Kurlander JL, Essoi B, Yang J, Mahableshwarkar AR, Samp JC, Akhras KS. Association between cognitive function and health care costs 3 months and 6 months after initiating antidepressant medication for depressive disorders. J Manag Care Spec Pharm. 2015 Sep;21(9):742-52.
Khanna PP, Shiozawa A, Walker V, Bancroft T, Essoi B, Akhras KS, Khanna D. Health-related quality of life and treatment satisfaction in patients with gout disease: Results from a cross-sectional study in a managed care setting. Patient Prefer Adherence. 2015 Jul;9:971-81.
Yu J, Brenneman SK, Sazonov V, Modi A. Reasons for not initiating osteoporosis therapy among a managed care population. Patient Prefer Adherence. 2015 Jun 19;9:821-30.
Zhang M, Brenneman SK, Carter C, Essoi B, Farahi K, Johnson MP, Lee S, Olson WH. Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment of moderate to severe plaque psoriasis. Patient Prefer Adherence. 2015 Jun;9:777–84.
Brenneman SK, Shen W, Brekke L, Paczkowski R, Bancroft T, Kaplan SH, Greenfield S, Berger M, Buesching DP. Field testing the ENSEMBLE minimum dataset: Performance of an instrument to address heterogeneity of treatment effects. J Comp Eff Res. 2014 Sep;3(5):463-72.
Ettinger A, Good M, Manjunath R, Faught E, Bancroft T. The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy Behav. 2014 Jul; 36:138-43.
Johnson P, Bancroft T, Barron R, Legg J, Li X, Watson H, Naeim A, Watkins A, Marshall D. Discrete choice experiment to estimate breast cancer patients’ preferences and willingness-to-pay for prophylactic granulocyte colony-stimulating factors. Value Health. 2014 June;17(4):380-89.
Bozeman SR, Hoaglin DC, Burton TM, Pashos CL, Ben-Joseph RH, Hollenbeak CS. Predicting waist circumference from body mass index. BMC Med Res Methodol. 2012 Aug;12:115.
Zimet G, Weiss T, Rosenthal S, Brenneman S, Klein J. Physician's sexual health discussions with adolescent males and attitudes about HPV vaccination. J Adolesc Health Care. 2011 Feb;48(2):S27-28.
Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine. 2011 Jan 29;29(5):890-95.
Zimet GD, Stupiansky NW, Weiss TW, Rosenthal SL, Good MB, Vichnin M. Influence of patient’s relationship status and HPV history on physicians’ decisions to recommend HPV vaccination. Vaccine. 2011 Jan;29(3):378-81.
Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Women’s Health. 2010 Sep 1;10:27.
Weiss T, Zimet G, Rosenthal S, Brenneman S, Klein J. HPV vaccination of males: Attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010 Jul;47(1)3-11.
Copher R, Buzinec P, Zarotsky V, Kazis L, Iqbal SU, Macarios D. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims. Curr Med Res Opin. 2010 Apr;26(4):777-85.
Yazici Y, McMorris BJ, Darkow T, Rosenblatt LC. Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2009 Nov-Dec;27(6):907-13.
Krahn DD, Bohn MJ, Henk HJ, Grossman JL, Gosnell B. Patterns of Urges during Early Abstinence in Alcohol-dependent Subjects. Am J Addict. 2005 May-Jun;14(3):248-55.
Related healthcare insights
White paper
Read how you can fill the data divide to develop effective treatment options.
Article
RWD pitfalls part 1: When working with real-world data, learn from the lessons of others to help maximize your own business return.
Article
Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.